Anthropometry of patients with osteogenesis imperfecta

Archives of Disease in Childhood

Volumn 80, Issue 6, 1999, Pages 524-528

  Lund, Allan M ^a   Müller, Jørn ^a   Skovby, Flemming ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Anthropometry; Body constitution; Collagen; Osteogenesis imperfecta

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ANTHROPOMETRY; ARM; ARTICLE; BODY HEIGHT; COLLAGEN DEFECT; FEMALE; GROWTH HORMONE BLOOD LEVEL; HEAD CIRCUMFERENCE; HUMAN; LEG LENGTH; MAJOR CLINICAL STUDY; MALE; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; SHORT STATURE; SITTING; STANDING;

EID: 0032990522     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.80.6.524     Document Type: Article

References (24)

1. 1 Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101-16.
2. 2 Sykes B. Linkage analysis in dominantly inherited osteogenesis imperfecta. Am J Med Genet 1993;45:212-16.
3. 3 Willing MC, Pruchno CJ, Atkinson M, Byers PH, Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet 1992;51:508-15.
4. 4 Willing MC, Deschenes SP, Scott DA, et al. Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet 1994;55:638-47.
5. 5 Steinmann B, Rao VH, Vogel A, Bruckner P, Gitzelmann R, Byers PH. Cysteine in the triple-helical domain of one allelic product of the α1(1) gene of type I collagen produces a lethal form of osteogenesis imperfecta. J Biol Chem 1984; 259:11129-38.
6. 6 Lund AM, Skovby F, Schwartz M. Deletion of a Gly-Pro-Pro repeat in the proα2(I) chain of procollagen 1 in a family with dominant osteogenesis imperfecta type IV. Hum Genet 1996;97:287-90.
7. 7 Lund AM, Schwartz M, Raghunath M, Steinmann B, Skovby F. Gly802Asp substitution in the proα2(1) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism. Eur J Hum Genet 1996;4:39-45.
8. 8 Lund AM, Skovby F, Schwartz M. Serine for glycine substitutions in the C-terminal third of the α1(I) chain of collagen I in five patients with non-lethal osteogenesis imperfecta. Hum Mutat 1997;9:378-82.
9. 9 Byers PH. Osteogenesis imperfecta. In: Royce PM, Steinmann B, eds. Connective tissue and its heritable disorders: molecular, genetic and medical aspects. 1st ed. New York: Wiley-Liss, 1993:317-50.
10. 10 Vetter U, Pontz B, Zauner E, Brenner RE, Spranger J. Osteogenesis imperfecta: a clinical study of the first ten years of life. Calcif Tissue Int 1992;50:36-41.
11. 11 Andersen E, Hutchings B, Jansen J, Nyholm M, Højde og vægt hos danske børn. Ugeskr Læger 1982;144:1760-5.
12. 12 Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976;51:170-9.
13. 13 Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta 1989;52(suppl):1-125.
14. 14 Juul A, Bang P, Hertel NT, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-52.
15. 15 Juul A, Dalgaard P, Blum WF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42.
16. 16 Lund AM, Schwartz M, Skovby F. Variable clinical expression in a family with OI type IV due to deletion of three base pairs in COL1A1. Clin Genet 1996;50:304-9.
17. 17 Lund AM, Nicholls AC, Schwartz M, Skovby F. Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent findings in families with osteogenesis imperfecta type III/IV. Acta Paediatr 1997;86:711-18.
18. 18 Sanguinetti C, Greco F, De Palma L, Specchia N, Falciglia F. Morphological changes in growth-plate cartilage in osteogenesis imperfecta. J Bone Joint Surg Br 1990;72:475-9.
19. 19 Marini JC, Bordenick S, Heavner G, et al. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta. J Clin Endocrinol Metab 993;76: 251-6.
20. 20 Shi ST, Kirk M, Kahn AJ. The role of type I collagen in the regulation of the osteoblast phenotype. J Bone Miner Res 1996;11:1139-45.
21. 21 Antoniazzi F, Bertoldo F, Mottes M, et al. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis. J Pediatr 1996;129:432-9.
22. 22 Willing MC, Deschenes SP, Slayton R, Roberts EJ. Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet 1996;59:799-809.
23. 33 Dutton RV. A practical radiologic approach to skeletal dysplasias in infancy. Radiol Clin North Am 1987;25:1211-33.
24. 24 Charnas LR, Marini JC. Communicating hydrocephalus, basilar invagination, and other neurologic features in osteogenesis imperfecta. Neurology 1993;43:2603-8